The MoU combines HMRI and the University of Newcastle's research expertise with Novartis' medical solutions leadership. It ...
On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...
"They don't bring forward proposals, but act as judges, prosecutors, experts, they pander to the public, they spew filth, and ...
Hello there. I don’t know if Mitsotakis got off easy back in 2018 with the rolling suitcases of the Novartis scandal—"the scandal of the century," as Mimi ...